BTAI vs BXP · rev $388.0K vs rev $895.7M
BioXcel Therapeutics Inc (BTAI) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported BXP revenue for 2026-06-30 was $895.7M. Net income was $68.6M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. BXP currently screens at market cap $12.12B.
BTAI currently screens at market cap $36.1M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the BTAI and BXP stock pages for the full models.
Not investment advice.